Renal biomarkers predict nephrotoxicity after paraquat

Toxicology Letters

Volumn 222, Issue 3, 2013, Pages 280-288

  Wunnapuk, Klintean ^a,b   Liu, Xin ^a   Peake, Philip ^c   Gobe, Glenda ^a   Endre, Zoltan ^c   Grice, Jeffrey E ^a   Roberts, Michael S ^a,d   Buckley, Nicholas A ^e,f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e UNIVERSITY OF PERADENIYA   (Sri Lanka)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Acute kidney injury; Creatinine; Cystatin C; Kidney injury molecule 1; Paraquat; Renal biomarker

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CLUSTERIN; CREATININE; CYSTATIN C; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PARAQUAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; HISTOLOGY; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; RECEIVER OPERATING CHARACTERISTIC; URINALYSIS;

ACUTE KIDNEY INJURY; CREATININE; CYSTATIN-C; KIDNEY INJURY MOLECULE-1; PARAQUAT; RENAL BIOMARKER;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ALBUMINURIA; ANIMALS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CLUSTERIN; CREATININE; CYSTATIN C; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; LIPOCALINS; MALE; OSTEOPONTIN; PARAQUAT; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; SERUM ALBUMIN;

EID: 84884197083     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.08.003     Document Type: Article

References (55)

1. Ben Rejeb A., Maillet M., Bescol-Liversaac J., Guillam-Megnin C. Ultrastructure of the kidney in paraquat-poisoned rats. Comparative study with literature data on man and animal. Arch. Anat. Cytol. Pathol. 1997, 45:199-207.
2. Bonventre J.V., Vaidya V.S., Schmouder R., Feig P., Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 2010, 28:436-440.
3. Chan B.S., Lazzaro V.A., Seale J.P., Duggin G.G. Transport of paraquat in a renal epithelial cell line LLC-PK1. J. Pharmacol. Exp. Ther. 1996, 279:625-632.
4. Coca S.G., Parikh C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. 2008, 3:481-490.
5. Coca S.G., Yalavarthy R., Concato J., Parikh C.R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008, 73:1008-1016.
6. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
7. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002, 40:221-226.
8. Dieterle F., Perentes E., Cordier A., Roth D.R., Verdes P., Grenet O., Pantano S., Moulin P., Wahl D., Mahl A., End P., Staedtler F., Legay F., Carl K., Laurie D., Chibout S.D., Vonderscher J., Maurer G. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol. 2010, 28:463-469.
9. Dieterle F., Sistare F., Goodsaid F., Papaluca M., Ozer J.S., Webb C.P., Baer W., Senagore A., Schipper M.J., Vonderscher J., Sultana S., Gerhold D.L., Phillips J.A., Maurer G., Carl K., Laurie D., Harpur E., Sonee M., Ennulat D., Holder D., Andrews-Cleavenger D., Gu Y.Z., Thompson K.L., Goering P.L., Vidal J.M., Abadie E., Maciulaitis R., Jacobson-Kram D., Defelice A.F., Hausner E.A., Blank M., Thompson A., Harlow P., Throckmorton D., Xiao S., Xu N., Taylor W., Vamvakas S., Flamion B., Lima B.S., Kasper P., Pasanen M., Prasad K., Troth S., Bounous D., Robinson-Gravatt D., Betton G., Davis M.A., Akunda J., McDuffie J.E., Suter L., Obert L., Guffroy M., Pinches M., Jayadev S., Blomme E.A., Beushausen S.A., Barlow V.G., Collins N., Waring J., Honor D., Snook S., Lee J., Rossi P., Walker E., Mattes W. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 2010, 28:455-462.
10. Dinis-Oliveira R.J., de Pinho P.G., Santos L., Teixeira H., Magalhaes T., Santos A., de Lourdes Bastos M., Remiao F., Duarte J.A., Carvalho F. Postmortem analyses unveil the poor efficacy of decontamination, anti-inflammatory and immunosuppressive therapies in paraquat human intoxications. PLoS ONE 2009, 4:e7149.
11. Dinis-Oliveira R.J., Duarte J.A., Remiao F., Sanchez-Navarro A., Bastos M.L., Carvalho F. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 2006, 227:73-85.
12. Dinis-Oliveira R.J., Duarte J.A., Sanchez-Navarro A., Remiao F., Bastos M.L., Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit. Rev. Toxicol. 2008, 38:13-71.
13. Dinis-Oliveira R.J., Pontes H., Bastos M.L., Remiao F., Duarte J.A., Carvalho F. An effective antidote for paraquat poisonings: the treatment with lysine acetylsalicylate. Toxicology 2009, 255:187-193.
14. Fairshter R.D., Dabir-Vaziri N., Smith W.R., Glauser F.L., Wilson A.F. Paraquat poisoning: an analytical toxicologic study of three cases. Toxicology 1979, 12:259-266.
15. Ferguson M.A., Vaidya V.S., Bonventre J.V. Biomarkers of nephrotoxic acute kidney injury. Toxicology 2008, 245:182-193.
16. Gawarammana I.B., Buckley N.A. Medical management of paraquat ingestion. Br. J. Clin. Pharmacol. 2011, 72:745-757.
17. Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Clin. Toxicol. (Phila.) 2009, 47:870-875.
18. Gunnell D., Eddleston M., Phillips M.R., Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007, 7:357.
19. Haase-Fielitz A., Bellomo R., Devarajan P., Story D., Matalanis G., Dragun D., Haase M. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study. Crit. Care Med. 2009, 37:553-560.
20. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
21. Hantson P., Bernard A., Hermans C. Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injury. Clin. Toxicol. (Phila.) 2008, 46:230-238.
22. Hawksworth G.M., Bennett P.N., Davies D.S. Kinetics of paraquat elimination in the dog. Toxicol. Appl. Pharmacol. 1981, 57:139-145.
23. Hedenmalm K., Alvan G., Ohagen P., Dahl M.L. Muscle toxicity with statins. Pharmacoepidemiol. Drug Saf. 2010, 19:223-231.
24. Hodel C. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol. Lett. 2002, 128:159-168.
25. Hoffmann D., Fuchs T.C., Henzler T., Matheis K.A., Herget T., Dekant W., Hewitt P., Mally A. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 2010, 277:49-58.
26. Kim J.H., Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. Serum uric acid level as a marker for mortality and acute kidney injury in patients with acute paraquat intoxication. Nephrol. Dial. Transplant. 2011, 26(6):1846-1852.
27. Kim S.J., Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol. Dial. Transplant. 2009, 24:1226-1232.
28. Li Q., Peng X., Yang H., Wang H., Shu Y. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice. Mol. Pharmacol. 2011, 8:2476-2483.
29. Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury. Blood Purif. 2010, 29:357-365.
30. Lock E.A. The effect of paraquat and diquat on renal function in the rat. Toxicol. Appl. Pharmacol. 1979, 48:327-336.
31. Lock E.A., Ishmael J. The acute toxic effects of paraquat and diquat on the rat kidney. Toxicol. Appl. Pharmacol. 1979, 50:67-76.
32. Marrer E., Dieterle F. Impact of biomarker development on drug safety assessment. Toxicol. Appl. Pharmacol. 2010, 243:167-179.
33. Martensson J., Martling C.R., Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability. Br. J. Anaesth. 2012, 109(6):843-850.
34. Murray R.E., Gibson J.E. Paraquat disposition in rats, guinea pigs and monkeys. Toxicol. Appl. Pharmacol. 1974, 27:283-291.
35. Nguyen M.T., Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr. Nephrol. 2008, 23:2151-2157.
36. Noiri E., Doi K., Negishi K., Tanaka T., Hamasaki Y., Fujita T., Portilla D., Sugaya T. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am. J. Physiol. Renal Physiol. 2009, 296:F669-F679.
37. Noto A., Cibecchini F., Fanos V., Mussap M. NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed. Res. Int. 2013, 2013:612032.
38. O'Donnell M.P., Burne M., Daniels F., Rabb H. Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury. Transplantation 2002, 73:1841-1844.
39. OECD OECD Guidelines for the Testing of Chemicals, Section 4 Health Effects. Test No 425: Acute Oral Toxicity: Up-and-Down Procedure 2008, vol. 4. OECD, OECD iLibrary.
40. Pond S.M., Rivory L.P., Hampson E.C., Roberts M.S. Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog. J. Toxicol. Clin. Toxicol. 1993, 31:229-246.
41. Prashad D.N., Chambers D., Beadle D.J. Changes in renal function associated with paraquat dichloride toxicity in the domestic fowl. Gen. Pharmacol. 1981, 12:291-293.
42. Purser D.A., Rose M.S. The toxicity and renal handling of paraquat in cynomolgus monkeys. Toxicology 1979, 15:31-41.
43. Qi Z., Whitt I., Mehta A., Jin J., Zhao M., Harris R.C., Fogo A.B., Breyer M.D. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am. J. Physiol. Renal Physiol. 2004, 286:F590-F596.
44. Ralib A.M., Pickering J.W., Shaw G.M., Devarajan P., Edelstein C.L., Bonventre J.V., Endre Z.H. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J. Am. Soc. Nephrol.: JASN 2012, 23:322-333.
45. Roberts D.M., Wilks M.F., Roberts M.S., Swaminathan R., Mohamed F., Dawson A.H., Buckley N.A. Changes in the concentrations of creatinine, cystatin C and NGAL in patients with acute paraquat self-poisoning. Toxicol. Lett. 2011, 202:69-74.
46. Rouse R.L., Zhang J., Stewart S.R., Rosenzweig B.A., Espandiari P., Sadrieh N.K. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int. 2011, 79(11):1186-1197.
47. Takahashi N., Boysen G., Li F., Li Y., Swenberg J.A. Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int. 2007, 71:266-271.
48. Toto R.D. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr. Opin. Nephrol. Hypertens. 1995, 4:505-509. discussion 503-504.
49. Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 2008, 48:463-493.
50. Vaidya V.S., Waikar S.S., Ferguson M.A., Collings F.B., Sunderland K., Gioules C., Bradwin G., Matsouaka R., Betensky R.A., Curhan G.C., Bonventre J.V. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin. Transl. Sci. 2008, 1:200-208.
51. Waikar S.S., Sabbisetti V.S., Bonventre J.V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int. 2010, 78:486-494.
52. Webb D.B. Nephrotoxicity of paraquat in the sheep and the associated reduction in paraquat secretion. Toxicol. Appl. Pharmacol. 1983, 68:282-289.
53. Westhuyzen J., Endre Z.H., Reece G., Reith D.M., Saltissi D., Morgan T.J. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol. Dial. Transplant. 2003, 18:543-551.
54. Woitas R.P., Stoffel-Wagner B., Flommersfeld S., Poege U., Schiedermaier P., Klehr H.U., Spengler U., Bidlingmaier F., Sauerbruch T. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin. Chem. 2000, 46:712-715.
55. Wunnapuk K., Medley G.A., Liu X., Grice J.E., Jayasinghe S., Gawarammana I., Buckley N.A., Roberts M.S. Simple and sensitive liquid chromatography-tandem mass spectrometry methods for quantification of paraquat in plasma and urine: application to experimental and clinical toxicological studies. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2011, 879:3047-3052.